Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

Nov 13, 2015

30071_dirs_2015-11-13_82db2927-afaf-40d0-88de-762447ba8c3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-11

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-11 ResMed Common Stock F 5965 $58.37 Disposed 166669.849 Direct
2015-11-11 ResMed Common Stock F 3006 $58.37 Disposed 163663.849 Direct
2015-11-11 ResMed Common Stock F 3631 $58.37 Disposed 160032.849 Direct
2015-11-11 ResMed Common Stock F 6470 $58.37 Disposed 153562.849 Direct
2015-11-11 ResMed Common Stock F 8685 $58.37 Disposed 144877.849 Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/16/2011.

F2: Includes 264.903 shares purchased on October 30, 2015, through ResMed's Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/15/2012.

F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 3/1/2013.

F5: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013.

F6: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2014.